Salim Virani, MD, PhD, staff cardiologist at the Michael E. DeBakey VA Medical Center in Houston, vice provost for research and professor at the Aga Khan University in Karachi, Pakistan, and staff at The Texas Heart Institute/Baylor College of Medicine.
March 05, 2023
Targeted Reminders Increase Prescriptions for High-Intensity Statins
March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease,…
Read More
Tor Biering-Sørensen, MD, MSc, MPH, PhD, professor, Center for Translational Cardiology and Pragmatic Randomized Trials, Copenhagen University Hospital,
March 05, 2023
Linking Flu Vaccination to Potential Cardiovascular Benefits Gets More People to Roll Up Their Sleeves
March 5, 2023 — Making a connection between the flu and the risk of subsequent heart problems significantly increased…
Read More
Amrita Mukhopadhyay, MD, cardiologist and clinical investigator at NYU Grossman School of Medicine in New York City
March 05, 2023
Prescribing of Key Heart Failure Medications Improved with Tailored Digital Alerts
March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5…
Read More
John K. Forrest, MD, director of interventional cardiology and structural heart disease at Yale University School of Medicine
March 05, 2023
Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years
March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with…
Read More
Nearly 40% risk reduction seen with intravascular imaging compared with angiography alone
March 05, 2023
Stenting With Close Look Inside Blood Vessel Improves Outcomes in Patients with Complex Coronary Artery Disease
March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by…
Read More
In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
March 05, 2023
Immediate Complete Revascularization as Safe and Effective as Staged Procedure in Treating Multi-Vessel Disease
March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with…
Read More
COAPT trial demonstrates long-term benefits of transcatheter procedure in high-risk patients with heart failure
March 05, 2023
Minimally Invasive Mitral Valve Repair Reduces Hospitalizations and Deaths
March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure…
Read More
Newer technique is equally safe and effective when performed by experienced surgeons, according to investigators
March 05, 2023
Similar Recovery Seen for Patients Receiving Minimally Invasive and Conventional Surgery for Mitral Valve Repair
March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac…
Read More
The Opening Showcase of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, featured comments from Ed Fry, MD, ACC President, shown here, the event Chair and World Heart Federation President. the 3-day global gathering of cardiologists is taking place March 4-6 in New Orleans, LA.
Christine Book
March 04, 2023
Important Clinical Trial Outcomes, the Evolution of Cardiac ICU and Young Authors Take Center Stage for Global Gathering of Cardiologists in New Orleans ACC.23/WCC
March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the…
Read More
March 04, 2023
STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports
March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus…
Read More
March 04, 2023
TRILUMINATE Pivotal Trial Findings Reported at ACC.23/WCC Reveal Impact of Improved Tricuspid Valve Functioning
March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or…
Read More
Statistically significant reduction in the risk for the primary outcome on Day 27
March 04, 2023
New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23
March 4, 2023 - Lexicon Pharmaceuticals, Inc.  announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes…
Read More
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism
March 04, 2023
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
March 4, 2023 — Viz.ai, a leader in AI-powered disease detection and care coordination, announced it will use its VizTM…
Read More
March 04, 2023
CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients
March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse…
Read More
Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)
March 04, 2023
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation
March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a…
Read More
March 04, 2023
GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC
March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning…
Read More
iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference
March 03, 2023
Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC
March 3, 2023 —  iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions…
Read More
Machine learning can be used to help clinicians with early diagnosis
March 03, 2023
Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease
March 3, 2023 —  Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart…
Read More
Machine learning can be used to help clinicians with early diagnosis
March 03, 2023
CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023
March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC)…
Read More
Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, taking place March 4-6, 2023, in New Orleans, LA.
March 03, 2023
ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms
March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now